Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment

被引：0
作者：
Mickaël Hiligsmann
Benedict G Dellaert
Carmen D Dirksen
Trudy van der Weijden
Stefan Goemaere
Jean-Yves Reginster
Verity Watson
Annelies Boonen
机构：
[1] Maastricht University,Department of Health Services Research, School for Public Health and Primary Care (CAPHRI)
[2] Erasmus Rotterdam University,Department of Business Economics
[3] CAPHRI,Department of Clinical Epidemiology and Medical Technology Assessment
[4] Maastricht University,Department of Family Medicine
[5] CAPHRI,Department of Rheumatology and Endocrinology
[6] Maastricht University,Department of Public Health, Epidemiology and Health Economics
[7] Ghent University Hospital,Health Economics Research Unit, Institute of Applied Health Sciences
[8] University of Liege,Department of Internal Medicine
[9] University of Aberdeen,undefined
[10] CAPHRI,undefined
[11] Maastricht University,undefined
来源：
Arthritis Research & Therapy | / 16卷
关键词：
Osteoporosis; Denosumab; Choice Task; Discrete Choice Experiment; Mixed Logit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 161 条
[11]  
Murphy DR(2007)A systematic review of persistence and compliance with bisphosphonates for osteoporosis Osteoporos Int 18 1023-677
[12]  
Smolen LJ(2013)Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis Patient Prefer Adherence 7 133-741
[13]  
Klein TM(2008)Conducting discrete choice experiments to inform healthcare decision making: a user’s guide Pharmacoeconomics 26 661-104
[14]  
Klein RW(2012)Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations Health Econ 21 730-13
[15]  
de Bekker-Grob EW(2011)Adverse reactions and drug–drug interactions in the management of women with postmenopausal osteoporosis Calcif Tissue Int 89 91-S13
[16]  
Ryan M(2013)Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force Value Health 16 3-612
[17]  
Gerard K(2012)Comparing hospital mortality – how to count does matter for patients hospitalized for acute myocardial infarction (AMI), stroke and hip fracture BMC Health Serv Res 12 364-921
[18]  
Marshall D(2009)Impact of osteoporosis treatment adherence on fracture rates in North America and Europe Am J Med 122 S3-765
[19]  
Bridges JF(2012)The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland Value Health 15 604-14
[20]  
Hauber B(2006)Treatment of Osteoporosis in clinical Practice (TOP) Study Group Osteoporos Int 17 914-556
12345678910